Teleflex shares rise on Q2 beat and raise

Shares in Teleflex (NYSE:TFX) rose today after the medical device maker topped expectations on Wall Street with its 2nd quarter earnings results, providing lifted guidance for the rest of its fiscal year. The Wayne, Pa.-based company posted profits of $78 million, or $1.67 per share, on sales of $528.6 million for the 3 months ended June 30,

Teleflex Medical OEM announces bioabsorbable sutures, yarns and resins

Teleflex Medical OEM, a global developer in fiber-based products, announces the availability of bioabsorbable sutures, yarns and resins that can be custom-configured to meet the performance requirements for specific applications. The bioabsorbable product portfolio includes: Bondek Plus and Monodek sutures; multi-filament yarns constructed of PGA (polyglycolic acid), PLLA (poly-L-lactic acid) and PGLA (poly acid-co-poly-L-lactic acid); and

Teleflex launches second-generation 2.9 mm Percuvance System

Teleflex, a global provider of medical technologies for critical care and surgery, has announced that it has officially launched its second-generation Percuvance Percutaneous Surgical System and that the first clinical laparoscopic procedures in the U.S. using the system were performed at the Duke Center for Metabolic and Weight Loss Surgery. Teleflex’s latest advance in percutaneous

Teleflex Medical OEM adds balloon catheter capabilities

Teleflex Medical OEM announces the addition of balloon catheter manufacturing technologies to its extensive portfolio of in-house capabilities. New product offerings include non-compliant, semi-compliant and compliant medical balloons for a variety of peripheral, coronary and neurovascular applications. Teleflex specializes in components for percutaneous transluminal coronary angioplasty (PTCA) and percutaneous transluminal angioplasty (PTA) procedures. As a